[Physiological principles of diuretic therapy].
D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004231:Diuresis; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006801:Humans; D007684:Kidney Tubules / Q000378:metabolism; D009941:Organomercury Compounds / Q000627:therapeutic use; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013449:Sulfonamides / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics; D009941:Organomercury Compounds; D013449:Sulfonamides; D014970:Xanthines; D012964:Sodium; D004976:Ethacrynic Acid; D011188:Potassium
Fysiologické základy lécby diuretiky.